A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects

NCT01608542 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Japanese Volunteers

Interventions

DRUG: Fostamatinib 100mg
DRUG: Fostamatinib 200mg

Sponsor

AstraZeneca